Biodegradable Implant with [Poly(PDL-co-DO)] Co-polymers

Description: A biodegradable implant that can achieve 18 months duration using novel [Poly(PDL-co-DO)] co-polymers.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: 18 months

Regimen:
  • Single administration every 18 months

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: pentadecalactone; dioxanone

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: FHI 360, Yale University

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Began discovery in: 2014

Active Development: Yes

Additional Information

References:

Vertical Tabs

Print